Blake Borgeson
Director at Recursion Pharmaceuticals, Inc. (RXRX)
Blake Borgeson has filed 83 insider reports with the SEC since April 2021, as director at Recursion Pharmaceuticals, Inc. (RXRX). In the last 12 months Blake Borgeson sold $4.25M of stock on the open market. In the latest filing, on November 4, 2026, Blake Borgeson sold 40,000 shares of Recursion Pharmaceuticals, Inc. (RXRX) for $155K at an average of $3.88.
- Filings
- 83
- Companies
- 1
- Bought on market
- None
- Sold on market
- $10.5M
Companies where Blake Borgeson is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 6,068,287 | $10.5M | $2.45 | Nov 4, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 3, 2026-$155KRXRXDirector Borgeson Blake sold $155,200 worth of shares (40,000 units at $3.88) as part of a pre-agreed trading plan, decreasing direct ownership by 0.65% to 6,068,287 unitsForm 4Open-market sale10b5-1 plan
- Sep 1, 2026-$100KRXRXDirector Borgeson Blake sold $100,200 worth of shares (30,000 units at $3.34) as part of a pre-agreed trading plan, decreasing direct ownership by 0.48% to 6,158,287 unitsForm 4Open-market sale10b5-1 plan
- Aug 4, 2026-$97.5KRXRXDirector Borgeson Blake sold $97,500 worth of shares (30,000 units at $3.25) as part of a pre-agreed trading plan, decreasing direct ownership by 0.48% to 6,188,287 unitsForm 4Open-market sale10b5-1 plan
- Jul 7, 2026-$159KRXRXDirector Borgeson Blake sold $158,500 worth of shares (40,000 units at $3.96) as part of a pre-agreed trading plan, decreasing direct ownership by 0.64% to 6,218,287 unitsForm 4Open-market sale10b5-1 plan
- Jun 17, 2026RXRXDirector Borgeson Blake was granted 88,424 shares, increasing direct ownership by 1% to 6,258,287 unitsForm 4Grant or award
- Jun 2, 2026-$110KRXRXDirector Borgeson Blake sold $110,400 worth of shares (30,000 units at $3.68) as part of a pre-agreed trading plan, decreasing direct ownership by 0.48% to 6,169,863 unitsForm 4Open-market sale10b5-1 plan
- May 5, 2026-$106KRXRXDirector Borgeson Blake sold $105,600 worth of shares (30,000 units at $3.52) as part of a pre-agreed trading plan, decreasing direct ownership by 0.48% to 6,199,863 unitsForm 4Open-market sale10b5-1 plan
- Apr 7, 2026-$93KRXRXSEC Form 4 filed by Borgeson BlakeForm 4Open-market sale10b5-1 plan
- Mar 3, 2026-$588KRXRXDirector Borgeson Blake sold $588,200 worth of shares (170,000 units at $3.46), decreasing direct ownership by 3% to 6,259,863 unitsForm 4Open-market sale
- Feb 3, 2026-$924KRXRXDirector Borgeson Blake sold $924,000 worth of shares (220,000 units at $4.20), decreasing direct ownership by 3% to 6,429,863 unitsForm 4Open-market sale10b5-1 plan
- Jan 6, 2026-$959KRXRXDirector Borgeson Blake sold $959,200 worth of shares (220,000 units at $4.36), decreasing direct ownership by 3% to 6,649,863 unitsForm 4Open-market sale10b5-1 plan
- Dec 2, 2025-$961KRXRXDirector Borgeson Blake sold $961,400 worth of shares (220,000 units at $4.37), decreasing direct ownership by 3% to 6,869,863 unitsForm 4Open-market sale10b5-1 plan
- Jun 18, 2025RXRXDirector Borgeson Blake was granted 22,016 shares, increasing direct ownership by 0.31% to 7,089,863 unitsForm 4Grant or award
- Jan 2, 2025RXRXDirector Borgeson Blake was granted 1,734 shares, increasing direct ownership by 0.02% to 7,067,847 unitsForm 4Grant or award
- Nov 12, 2024-$87.5KRXRXDirector Borgeson Blake sold $87,457 worth of shares (11,447 units at $7.64), decreasing direct ownership by 0.16% to 7,066,113 unitsForm 4Open-market sale10b5-1 plan
- Oct 29, 2024-$76.9KRXRXDirector Borgeson Blake sold $76,926 worth of shares (11,447 units at $6.72), decreasing direct ownership by 0.16% to 7,077,560 unitsForm 4Open-market sale10b5-1 plan
- Oct 15, 2024-$76.3KRXRXDirector Borgeson Blake sold $76,326 worth of shares (11,447 units at $6.67), decreasing direct ownership by 0.16% to 7,089,007 unitsForm 4Open-market sale10b5-1 plan
- Oct 1, 2024RXRXDirector Borgeson Blake was granted 2,026 shares, increasing direct ownership by 0.03% to 7,100,454 unitsForm 4Grant or award
- Oct 1, 2024-$71.1KRXRXDirector Borgeson Blake sold $71,150 worth of shares (11,447 units at $6.22), decreasing direct ownership by 0.16% to 7,098,428 unitsForm 4Open-market sale10b5-1 plan
- Sep 17, 2024-$78.3KRXRXDirector Borgeson Blake sold $78,333 worth of shares (11,447 units at $6.84), decreasing direct ownership by 0.16% to 7,109,875 unitsForm 4Open-market sale10b5-1 plan
- Sep 3, 2024-$71.7KRXRXDirector Borgeson Blake sold $71,718 worth of shares (11,447 units at $6.27), decreasing direct ownership by 0.16% to 7,121,322 unitsForm 4Open-market sale10b5-1 plan
- Aug 20, 2024-$81.5KRXRXDirector Borgeson Blake sold $81,532 worth of shares (11,447 units at $7.12), decreasing direct ownership by 0.16% to 7,132,769 unitsForm 4Open-market sale10b5-1 plan
- Aug 6, 2024-$78.1KRXRXDirector Borgeson Blake sold $78,083 worth of shares (11,447 units at $6.82), decreasing direct ownership by 0.16% to 7,144,216 unitsForm 4Open-market sale10b5-1 plan
- Jul 23, 2024-$97KRXRXDirector Borgeson Blake sold $97,041 worth of shares (11,447 units at $8.48), decreasing direct ownership by 0.16% to 7,155,663 unitsForm 4Open-market sale10b5-1 plan
- Jul 9, 2024-$83.7KRXRXDirector Borgeson Blake sold $83,735 worth of shares (11,447 units at $7.32), decreasing direct ownership by 0.16% to 7,167,110 unitsForm 4Open-market sale10b5-1 plan
- Jul 1, 2024RXRXDirector Borgeson Blake was granted 1,441 shares, increasing direct ownership by 0.02% to 7,178,557 unitsForm 4Grant or award
- Jun 25, 2024-$109KRXRXDirector Borgeson Blake sold $108,806 worth of shares (11,447 units at $9.51), decreasing direct ownership by 0.16% to 7,177,116 unitsForm 4Open-market sale10b5-1 plan
- Jun 11, 2024-$96.8KRXRXDirector Borgeson Blake sold $96,763 worth of shares (11,447 units at $8.45), decreasing direct ownership by 0.16% to 7,188,563 unitsForm 4Open-market sale10b5-1 plan
- Jun 3, 2024RXRXBorgeson Blake was granted 13,097 shares, increasing direct ownership by 0.18% to 7,200,010 unitsForm 4Grant or award
- May 28, 2024-$105KRXRXBorgeson Blake sold $104,943 worth of shares (11,447 units at $9.17), decreasing direct ownership by 0.16% to 7,186,913 unitsForm 4Open-market sale10b5-1 plan
- May 14, 2024-$203KRXRXBorgeson Blake sold $202,934 worth of shares (20,054 units at $10.12), decreasing direct ownership by 0.28% to 7,198,360 unitsForm 4Open-market sale10b5-1 plan
- Apr 30, 2024-$91KRXRXBorgeson Blake sold $90,964 worth of shares (11,447 units at $7.95), decreasing direct ownership by 0.16% to 7,218,414 unitsForm 4Open-market sale10b5-1 plan
- Apr 16, 2024-$87.7KRXRXBorgeson Blake sold $87,725 worth of shares (11,447 units at $7.66), decreasing direct ownership by 0.16% to 7,229,861 unitsForm 4Open-market sale10b5-1 plan
- Apr 2, 2024-$101KRXRXBorgeson Blake sold $100,942 worth of shares (11,447 units at $8.82), decreasing direct ownership by 0.16% to 7,241,308 unitsForm 4Open-market sale10b5-1 plan
- Mar 19, 2024-$216KRXRXBorgeson Blake sold $216,423 worth of shares (20,054 units at $10.79), decreasing direct ownership by 0.28% to 7,252,755 unitsForm 4Open-market sale10b5-1 plan
- Mar 5, 2024-$242KRXRXBorgeson Blake sold $241,805 worth of shares (20,054 units at $12.06), decreasing direct ownership by 0.27% to 7,272,809 unitsForm 4Open-market sale10b5-1 plan
- Feb 20, 2024-$247KRXRXBorgeson Blake sold $247,125 worth of shares (20,054 units at $12.32), decreasing direct ownership by 0.27% to 7,292,863 unitsForm 4Open-market sale10b5-1 plan
- Feb 6, 2024-$106KRXRXBorgeson Blake sold $106,489 worth of shares (11,447 units at $9.30), decreasing direct ownership by 0.16% to 7,312,917 unitsForm 4Open-market sale10b5-1 plan
- Jan 23, 2024-$212KRXRXBorgeson Blake sold $212,083 worth of shares (20,054 units at $10.58), decreasing direct ownership by 0.27% to 7,324,364 unitsForm 4Open-market sale10b5-1 plan
- Jan 9, 2024-$273KRXRXBorgeson Blake sold $273,202 worth of shares (20,054 units at $13.62), decreasing direct ownership by 0.27% to 7,344,418 unitsForm 4Open-market sale10b5-1 plan
- Dec 26, 2023-$213KRXRXBorgeson Blake sold $213,144 worth of shares (20,054 units at $10.63), decreasing direct ownership by 0.27% to 7,364,472 unitsForm 4Open-market sale10b5-1 plan
- Dec 12, 2023-$84.7KRXRXBorgeson Blake sold $84,693 worth of shares (11,447 units at $7.40), decreasing direct ownership by 0.15% to 7,384,526 unitsForm 4Open-market sale10b5-1 plan
- Nov 28, 2023-$76.9KRXRXBorgeson Blake sold $76,918 worth of shares (11,447 units at $6.72), decreasing direct ownership by 0.15% to 7,395,973 unitsForm 4Open-market sale10b5-1 plan
- Nov 14, 2023-$56.2KRXRXBorgeson Blake sold $56,151 worth of shares (8,885 units at $6.32), decreasing direct ownership by 0.12% to 7,407,420 unitsForm 4Open-market sale10b5-1 plan
- Oct 31, 2023-$46.9KRXRXBorgeson Blake sold $46,864 worth of shares (8,885 units at $5.27), decreasing direct ownership by 0.12% to 7,416,305 unitsForm 4Open-market sale10b5-1 plan
- Oct 17, 2023-$58.5KRXRXBorgeson Blake sold $58,483 worth of shares (8,885 units at $6.58), decreasing direct ownership by 0.12% to 7,425,190 unitsForm 4Open-market sale10b5-1 plan
- Oct 3, 2023-$64.8KRXRXBorgeson Blake sold $64,778 worth of shares (8,885 units at $7.29), decreasing direct ownership by 0.12% to 7,434,075 unitsForm 4Open-market sale10b5-1 plan
- Sep 19, 2023-$74.3KRXRXSEC Form 4: Borgeson Blake sold $74,278 worth of shares (8,885 units at $8.36), decreasing direct ownership by 0.12% to 7,442,960 unitsForm 4Open-market sale10b5-1 plan
- Sep 5, 2023-$78.1KRXRXSEC Form 4: Borgeson Blake sold $78,136 worth of shares (8,885 units at $8.79), decreasing direct ownership by 0.12% to 7,451,845 unitsForm 4Open-market sale10b5-1 plan
- Aug 22, 2023-$79.2KRXRXSEC Form 4: Borgeson Blake sold $79,181 worth of shares (8,885 units at $8.91), decreasing direct ownership by 0.12% to 7,460,730 unitsForm 4Open-market sale10b5-1 plan
- Aug 8, 2023-$198KRXRXSEC Form 4: Borgeson Blake sold $198,283 worth of shares (17,770 units at $11.16), decreasing direct ownership by 0.24% to 7,469,615 unitsForm 4Open-market sale10b5-1 plan
- Jul 25, 2023-$273KRXRXSEC Form 4 filed by Borgeson BlakeForm 4GiftOpen-market sale10b5-1 plan
- Jul 11, 2023-$61.2KRXRXSEC Form 4 filed by Borgeson BlakeForm 4Open-market sale10b5-1 plan
- Jun 27, 2023-$65.6KRXRXSEC Form 4 filed by Borgeson BlakeForm 4Open-market sale10b5-1 plan
- Jun 16, 2023RXRXSEC Form 4 filed by Borgeson BlakeForm 4Grant or award
- Jun 13, 2023-$155KRXRXSEC Form 4 filed by Borgeson BlakeForm 4Open-market sale10b5-1 plan
- May 30, 2023-$78.1KRXRXSEC Form 4 filed by Borgeson BlakeForm 4Open-market sale10b5-1 plan
- May 16, 2023-$45.2KRXRXSEC Form 4 filed by Borgeson BlakeForm 4Open-market sale10b5-1 plan
- Apr 18, 2023-$52.7KRXRXSEC Form 4 filed by Borgeson BlakeForm 4Open-market sale10b5-1 plan
- Apr 4, 2023-$58KRXRXSEC Form 4 filed by Borgeson BlakeForm 4Open-market sale10b5-1 plan
- Mar 21, 2023-$65.7KRXRXSEC Form 4 filed by Borgeson BlakeForm 4Open-market sale10b5-1 plan
- Mar 7, 2023-$74KRXRXSEC Form 4: Borgeson Blake sold $73,989 worth of shares (8,885 units at $8.33) as part of a pre-agreed trading plan, decreasing direct ownership by 0.12% to 7,585,172 unitsForm 4Open-market sale10b5-1 plan
- Feb 21, 2023-$68.7KRXRXSEC Form 4: Borgeson Blake sold $68,708 worth of shares (8,885 units at $7.73) as part of a pre-agreed trading plan, decreasing direct ownership by 0.12% to 7,594,057 unitsForm 4Open-market sale10b5-1 plan
- Feb 7, 2023-$78.3KRXRXSEC Form 4: Borgeson Blake sold $78,263 worth of shares (8,885 units at $8.81) as part of a pre-agreed trading plan, decreasing direct ownership by 0.12% to 7,602,942 unitsForm 4Open-market sale10b5-1 plan
- Jan 24, 2023-$77.4KRXRXSEC Form 4: Borgeson Blake sold $77,368 worth of shares (8,885 units at $8.71) as part of a pre-agreed trading plan, decreasing direct ownership by 0.12% to 7,611,827 unitsForm 4Open-market sale10b5-1 plan
- Jan 10, 2023-$68.3KRXRXSEC Form 4: Borgeson Blake sold $68,283 worth of shares (8,885 units at $7.69) as part of a pre-agreed trading plan, decreasing direct ownership by 0.12% to 7,620,712 unitsForm 4Open-market sale10b5-1 plan
- Jan 3, 2023RXRXSEC Form 4: Borgeson Blake was granted 1,325 shares, increasing direct ownership by 0.02% to 7,629,597 unitsForm 4Grant or award
- Dec 27, 2022-$64.4KRXRXSEC Form 4: Borgeson Blake sold $64,373 worth of shares (8,885 units at $7.25) as part of a pre-agreed trading plan, decreasing direct ownership by 0.12% to 7,628,272 unitsForm 4Open-market sale10b5-1 plan
- Dec 13, 2022-$79.6KRXRXSEC Form 4: Borgeson Blake sold $79,598 worth of shares (8,885 units at $8.96) as part of a pre-agreed trading plan, decreasing direct ownership by 0.12% to 7,637,157 unitsForm 4Open-market sale10b5-1 plan
- Nov 29, 2022-$77.8KRXRXSEC Form 4: Borgeson Blake sold $77,786 worth of shares (8,885 units at $8.75) as part of a pre-agreed trading plan, decreasing direct ownership by 0.12% to 7,646,042 unitsForm 4Open-market sale10b5-1 plan
- Nov 16, 2022-$198KRXRXSEC Form 4: Borgeson Blake sold $197,610 worth of shares (17,770 units at $11.12) as part of a pre-agreed trading plan, decreasing direct ownership by 0.23% to 7,654,927 unitsForm 4Open-market sale10b5-1 plan
- Oct 3, 2022RXRXSEC Form 4: Borgeson Blake was granted 920 shares, increasing direct ownership by 0.01% to 7,672,697 unitsForm 4Grant or award
- Jul 1, 2022RXRXSEC Form 4: Borgeson Blake was granted 1,186 shares, increasing direct ownership by 0.02% to 7,671,777 unitsForm 4Grant or award
- Jun 14, 2022RXRXSEC Form 4: Borgeson Blake was granted 18,145 shares, increasing direct ownership by 0.24% to 7,670,591 unitsForm 4Grant or award
- Apr 1, 2022RXRXSEC Form 4: Borgeson Blake was granted 1,300 shares, increasing direct ownership by 0.02% to 7,652,446 unitsForm 4Grant or award
- Jan 4, 2022-$174KRXRXSEC Form 4: Borgeson Blake sold $173,528 worth of shares (9,625 units at $18.03) as part of a pre-agreed trading plan and was granted 555 shares, decreasing direct ownership by 0.12% to 7,651,146 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Dec 21, 2021-$180KRXRXSEC Form 4: Borgeson Blake sold $180,478 worth of shares (9,625 units at $18.75) as part of a pre-agreed trading plan, decreasing direct ownership by 0.13% to 7,660,216 unitsForm 4Open-market sale10b5-1 plan
- Dec 7, 2021-$196KRXRXSEC Form 4: Borgeson Blake sold $195,533 worth of shares (9,625 units at $20.32) as part of a pre-agreed trading plan, decreasing direct ownership by 0.13% to 7,669,841 unitsForm 4Open-market sale10b5-1 plan
- Nov 18, 2021-$182KRXRXSEC Form 4: Borgeson Blake sold $182,005 worth of shares (9,625 units at $18.91) as part of a pre-agreed trading plan, decreasing direct ownership by 0.13% to 7,679,466 unitsForm 4Open-market sale10b5-1 plan
- Oct 1, 2021RXRXSEC Form 4: Borgeson Blake was granted 457 shares, increasing direct ownership by 0.01% to 7,689,091 unitsForm 4Grant or award
- Jul 1, 2021RXRXSEC Form 4: Borgeson Blake was granted 278 units of Class A Common Stock, increasing direct ownership by 0.00% to 7,688,634 unitsForm 4Grant or award
- Apr 20, 2021RXRXSEC Form 4: Borgeson Blake converted 7,688,356 units into Class A Common Stock and converted 923,052 units into Common Stock, increasing direct ownership by 14% to 7,688,356 unitsForm 4Conversion of a derivative
- Apr 16, 2021RXRXSEC Form 4: Borgeson Blake was granted 6,250 units of Common Stock, increasing direct ownership by 0.09% to 6,765,304 unitsForm 4Grant or award
Compare Blake Borgeson with
- Blake Borgeson vs Ben R Taylor1 shared
- Blake Borgeson vs David Hallett1 shared
- Blake Borgeson vs Najat Khan1 shared
- Blake Borgeson vs Fred Hassan1 shared
- Blake Borgeson vs Zavain Dar1 shared
- Blake Borgeson vs Dean Y Li1 shared
Other insiders at the same companies
- Ben R TaylorRXRX
- David HallettRXRX
- Najat KhanRXRX
- Fred HassanRXRX
- Zavain DarRXRX
- Dean Y LiRXRX
- Robert HershbergRXRX
- Franziska MichorRXRX
- Elaine D SunRXRX
- Namandje BumpusRXRX
- Christopher GibsonRXRX
Questions about Blake Borgeson
- What is Blake Borgeson's role at Recursion Pharmaceuticals, Inc.?
- Blake Borgeson reports to the SEC as director at Recursion Pharmaceuticals, Inc. (RXRX), according to the latest filing on November 4, 2026.
- How many shares does Blake Borgeson own?
- After the latest filing that states it, Blake Borgeson directly owned 6,068,287 shares of Recursion Pharmaceuticals, Inc. (RXRX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Blake Borgeson bought or sold stock recently?
- The most recent open-market sale was on November 3, 2026: sold 40,000 shares of Recursion Pharmaceuticals, Inc. (RXRX) for $155K at an average of $3.88.
- How do I get alerts when Blake Borgeson files?
- Follow Blake Borgeson on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Blake Borgeson filed 2 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Blake Borgeson (SEC CIK 0001856094). Totals count each trade once, skipping amendments whose original is on file, from Apr 19, 2021 on. View on SEC EDGAR · Get this as JSON